‘We’re not taking away the arthritis, just the arthritis pain’ Pain medicine specialists at Rush have helped develop, and are among the first in the country to provide, a noninvasive treatme... Read more
“If these results are replicated in Alzheimer’s disease patients, it would open up a promising avenue of treatment of this devastating neurodegenerative disease.” Buphenyl, an FDA-approved m... Read more
Rush University Medical Center is conducting the nation’s first clinical study of an innovative stem cell drug, Cartistem, to repair knee cartilage damaged by aging, trauma or degenerative d... Read more